{"id":162961,"date":"2022-08-13T01:57:12","date_gmt":"2022-08-13T05:57:12","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/vyne-therapeutics-reports-second-quarter-2022-financial-results\/"},"modified":"2024-08-18T11:44:54","modified_gmt":"2024-08-18T15:44:54","slug":"vyne-therapeutics-reports-second-quarter-2022-financial-results","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/vyne-therapeutics-reports-second-quarter-2022-financial-results.php","title":{"rendered":"VYNE Therapeutics Reports Second Quarter 2022 Financial Results"},"content":{"rendered":"<p><![CDATA[BRIDGEWATER, N.J., Aug.  12, 2022  (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (\u201cVYNE\u201d or the \u201cCompany\u201d), a biopharmaceutical company developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced financial results for the three and six months ended June\u00a030, 2022.]]><\/p>\n<p>Original post:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/08\/12\/2497550\/0\/en\/VYNE-Therapeutics-Reports-Second-Quarter-2022-Financial-Results.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"VYNE Therapeutics Reports Second Quarter 2022 Financial Results\">VYNE Therapeutics Reports Second Quarter 2022 Financial Results<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Original post: VYNE Therapeutics Reports Second Quarter 2022 Financial Results <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/vyne-therapeutics-reports-second-quarter-2022-financial-results.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-162961","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162961"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=162961"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162961\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=162961"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=162961"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=162961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}